|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-4-16
|
|
pubmed:abstractText |
Hormonal treatments lasting 2-6 months inhibit spermatogenesis in men and have been proposed as germ cell protection against anticancer therapy. Because it is unthinkable to delay anticancer treatments, the authors investigated the protection afforded against irradiation of rats by 22 days of hormonal pretreatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0008-543X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
85
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1313-22
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10189137-Animals,
pubmed-meshheading:10189137-Epididymis,
pubmed-meshheading:10189137-Female,
pubmed-meshheading:10189137-Fertility,
pubmed-meshheading:10189137-Fetus,
pubmed-meshheading:10189137-Male,
pubmed-meshheading:10189137-Medroxyprogesterone,
pubmed-meshheading:10189137-Organ Size,
pubmed-meshheading:10189137-Pregnancy,
pubmed-meshheading:10189137-Radiation Dosage,
pubmed-meshheading:10189137-Radiation Injuries, Experimental,
pubmed-meshheading:10189137-Radiation-Protective Agents,
pubmed-meshheading:10189137-Rats,
pubmed-meshheading:10189137-Rats, Sprague-Dawley,
pubmed-meshheading:10189137-Spermatogenesis,
pubmed-meshheading:10189137-Testis,
pubmed-meshheading:10189137-Testosterone
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Short term pretreatment with medroxyprogesterone and testosterone may potentiate irradiation damage to spermatogenesis in rats.
|
|
pubmed:affiliation |
Groupe de Recherche en Urologie, Université Paris XI, Le Kremlin-Bicêtre, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
